Medmall Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 Cr
- Revenue Growth 44.81%
- Profit Growth 29.28%
- Ebitda -60.97%
- Net Worth 230.85%
- Total Assets 42.69%
About Medmall Pharmacy
Medmall Pharmacy Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 November 2018 (Six years and two months 20 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.20 Cr.
Kunal Kanodia and Devesh Kanodia serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999TG2018PTC128498
-
Company No.
128498
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Nov 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Medmall Pharmacy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devesh Kanodia
|
Director | 01-Apr-2020 | Current |
|
Kunal Kanodia
|
Director | 26-Nov-2018 | Current |
Financial Performance of Medmall Pharmacy.
Medmall Pharmacy Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.81% increase. The company also saw a substantial improvement in profitability, with a 29.28% increase in profit. The company's net worth Soared by an impressive increase of 230.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medmall Pharmacy?
In 2022, Medmall Pharmacy had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Utkarsh Polypet Private LimitedKunal Kanodia is a mutual person
-
Devesh Flexi Packs Llp
Devesh Kanodia is a mutual person
Charges (Loans)
₹12.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Sep 2023 | Hdfc Bank Limited | ₹1.20 Cr | Open |
How Many Employees Work at Medmall Pharmacy?
Unlock and access historical data on people associated with Medmall Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medmall Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medmall Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
